Downexpression of miRs was associated with tumor development, progression, and metastasis. This study explored the levels of miR-125b in patients with and to assess its diagnostic value and monitor treatment responses for patients with . A total of 379 individuals were recruited and assigned into the study groups. RT-qPCR analysis was performed to conﬁrm the association of miR-125b levels with tumor stages and treatment responses. The median levels of miR-125b in patients with EOC were signiﬁcantly lower than that other controls (P < 0.0001). miR-125b in patients with high FIGO stage (III+IV), lymph node metastasis and chemoresistance were lower than that in patients with early-stage (stage I+II; P < 0.001), without lymph metastasis (p= 0.032) and chemosensitivity (P< 0.001). Low levels of miR-125b had a poor prognosis in patiens with . Using a median value of 0.748 to separate EOC from other controls, the sensitivity and speciﬁcity reached 0.76 (95% CI 0.75 to 0.85) 0.416 (95% CI 0.26 to 0.55), respectively. miR-125b showed a statistically signiﬁcant difference between preoperative and postoperative patients in surgical patient groups (P = 0.003). miR-125b levels was lower in patients with chemoresistance that that in patients with chemosensitivity (P< 0.0001). Serum miR-125b in combination with serum CA125 improved both sensitivity and speciﬁcity in diagnosis of EOC (P< 0.001). This study demonstrated that miR-125b levels were a useful diagnostic biomarker and biomarker to predict the responses to chemotherapy in patients with EOC.
Improving performance of recently introduced flow cytometry-based approach of malignant cell screening in serous cavity effusion.
June 25, 2020
Machine segmentation of pelvic anatomy in MRI-assisted radiosurgery (MARS) for prostate cancer brachytherapy.
July 9, 2020
October 12, 2018
January 1, 2018
- ASCO – Lung CancerASCO.20 Virtual Scientific Program, held May 29 - 31, brought professionals from all over the world together to hear the brightest minds in oncology present state-of-the-art treatment modalities and new therapies.
- AACR-2020The American Association for Cancer Research is the world's oldest and largest professional association related to cancer research.
- ACC 2020The American College of Cardiology decided to cancel ACC.20/WCC due to COVID-19, which was scheduled to take place March 28-30 in Chicago. However, ACC.20/WCC Virtual Meeting continues to release cutting edge science and practice changing updates for cardiovascular professionals on demand and free through June 2020.
- ASCO 2019The 2019 ASCO Annual Meeting, taking place May 31-June 4 in Chicago, will bring together more than 32,000 oncology professionals from across the globe. The theme of this year’s conference is Caring for Every Patient, Learning From Every Patient.